Table of Contents
International Scholarly Research Notices
Volume 2014 (2014), Article ID 541727, 8 pages
http://dx.doi.org/10.1155/2014/541727
Research Article

Simultaneous Spectrophotometric Method for Determination of Emtricitabine and Tenofovir Disoproxil Fumarate in Three-Component Tablet Formulation Containing Rilpivirine Hydrochloride

Department of Pharmacy, Annamalai University, Tamil Nadu 608002, India

Received 20 May 2014; Accepted 24 October 2014; Published 16 November 2014

Academic Editor: Zsuzsanna Kuklenyik

Copyright © 2014 S. Venkatesan and N. Kannappan. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Rouzes, K. Berthoin, F. Xuereb et al., “Simultaneous determination of the antiretroviral agents: amprenavir, lopinavir, ritonavir, saquinavir and efavirenz in human peripheral blood mononuclear cells by high-performance liquid chromatography–mass spectrometry,” Journal of Chromatography B, vol. 813, no. 1-2, pp. 209–216, 2004. View at Publisher · View at Google Scholar
  2. S. Raffanti and D. Haas, Antimicrobial Agents: Anti-Retroviral Agents, McGraw-Hill, New York, NY, USA, 1990.
  3. D. J. Porche, “Tenofovir disoproxil fumarate (Viread),” The Journal of the Association of Nurses in AIDS Care, vol. 13, no. 3, pp. 100–102, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. H. B. Fung, E. A. Stone, and F. J. Piacenti, “Tenofovir disoproxil fumarate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infection,” Clinical Therapeutics, vol. 24, no. 10, pp. 1515–1548, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Y. Kavitha, G. Geetha, R. Hariprasad, R. Venkatnarayanan, and M. Kaviarasu, “Development and validation of RP-UPLC analytical method for simultaneous estimation of the emtricitabine, tenofovir disoproxil fumarate and rilpivirine and its pharmaceutical dosageform,” International Research Journal of Pharmacy, vol. 4, no. 1, pp. 150–155, 2013. View at Google Scholar
  6. D. Pranitha, C. Vanitha, P. Francies et al., “Simultaneous estimation of emtricitabine, tenofovir disoproxil fumarate, and rilpivirine in bulk form by RP-HPLC method,” Journal of Pharmacy Research, vol. 5, no. 8, pp. 4600–4602, 2012. View at Google Scholar
  7. K. Anandakumar, K. Kannan, and T. Vetrichelvan, “Development and validation of emtricitabine and tenofovir disoproxil fumerate in pure and in fixed dose combination by UV spectrophotometry,” Digest Journal of Nanomaterials and Biostructures, vol. 6, no. 3, pp. 1085–1090, 2011. View at Google Scholar · View at Scopus
  8. A. A. Atul, H. B. Charashila, and J. S. Sajai, “Application of UV-spectrophotometric methods for estimation of tenofovir disoproxil fumarate in tablets,” Pakistan Journal of Pharmaceutical Sciences, vol. 22, no. 1, pp. 27–29, 2009. View at Google Scholar · View at Scopus
  9. A. J. Pratap Reddy and I. E. Chakravarthy, “New spectrophotometric determination of tenofovir disoproxil fumaratein bulk and pharmaceutical dosage form,” IOSR Journal of Applied Chemistry, vol. 1, no. 2, pp. 29–33, 2012. View at Google Scholar
  10. T. S. Rani, K. Sujatha, K. Chitra et al., “Spectrophotometric methods for estimation of tenofovir disoproxil fumarate in tablet,” Research & Review: Journal of Pharmaceutical Analysis, vol. 1, no. 1, pp. 9–12, 2012. View at Google Scholar
  11. J. O. Onah and U. Ajima, “Spectrophotometric determination of tenofovir disoproxil fumarate after complexation with ammonium molybdate and picric acid,” International Journal of Drug Development and Research, vol. 3, no. 1, pp. 199–204, 2011. View at Google Scholar · View at Scopus
  12. H. K. Ashour and T. S. Belal, “New simple spectrophotometric method for determination of the antiviral mixture of emtricitabine and tenofovir disoproxil fumarate,” Arabian Journal of Chemistry, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Patel, U. S. Baghel, P. Rajesh, D. Prabhakar, G. Engla, and P. N. Nagar, “Spectrophotometric method development Tenofovir disoproxil fumarate and Emtricitabine in Bulk drug and Tablet dosage Form,” International Journal of Pharmaceutical and Clinical Research, vol. 1, no. 1, pp. 28–30, 2009. View at Google Scholar
  14. P. B. Kandagal, D. H. Manjunatha, J. Seetharamappa, and S. S. Kalanur, “RP-HPLC method for the determination of tenofovir in pharmaceutical formulations and spiked human plasma,” Analytical Letters, vol. 41, no. 4, pp. 561–570, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. M. E. Barkil, M.-C. Gagnieu, and J. Guitton, “Relevance of a combined UV and single mass spectrometry detection for the determination of tenofovir in human plasma by HPLC in therapeutic drug monitoring,” Journal of Chromatography B, vol. 854, no. 1-2, pp. 192–197, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Jullien, J.-M. Tréluyer, G. Pons, and E. Rey, “Determination of tenofovir in human plasma by high-performance liquid chromatography with spectrofluorimetric detection,” Journal of Chromatography B, vol. 785, no. 2, pp. 377–381, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. R. W. Sparidans, K. M. L. Crommentuyn, J. H. M. Schellens, and J. H. Beijnen, “Liquid chromatographic assay for the antiviral nucleotide analogue tenofovir in plasma using derivatization with chloroacetaldehyde,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 791, no. 1-2, pp. 227–233, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Joshi, A. P. Nikalje, M. Shahed, and M. Dehghan, “HPTLC method for the simultaneous estimation of emtricitabine and tenofovir in tablet dosage form,” Indian Journal of Pharmaceutical Sciences, vol. 71, no. 1, pp. 95–97, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Delahunty, L. Bushman, and C. V. Fletcher, “Sensitive assay for determining plasma tenofovir concentrations by LC/MS/MS,” Journal of Chromatography B, vol. 830, no. 1, pp. 6–12, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. P. T. Nagaraju, K. P. Channabasavaraj, and P. T. Shantha Kumar, “Development and validation of spectrophotometric method for estimation of emtricitabine in tablet dosage form,” International Journal of ChemTech Research, vol. 3, no. 1, pp. 23–28, 2011. View at Google Scholar · View at Scopus
  21. B. Ahindita, P. Aurobinda, K. M. Amit, G. S. Dannana, K. M. Swapna, and C. S. I. Sudam, “Development and validation of spectrophotometric methods for determination of emtricitabine and tenofovir disoproxil fumarate in bulk and tablet dosage form,” International Journal of PharmTech Research, vol. 3, no. 3, pp. 1874–1882, 2011. View at Google Scholar
  22. N. L. Rezk, R. D. Crutchley, and A. D. M. Kashuba, “Simultaneous quantification of emtricitabine and tenofovir in human plasma using high-performance liquid chromatography after solid phase extraction,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 822, no. 1-2, pp. 201–208, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. J. A. H. Droste, R. E. Aarnoutse, and D. M. Burger, “Determination of emtricitabine in human plasma using HPLC with fluorometric detection,” Journal of Liquid Chromatography and Related Technologies, vol. 30, no. 10, pp. 2769–2778, 2007. View at Google Scholar · View at Scopus
  24. D. Ashenafi, A. Verbeek, J. Hoogmartens, and E. Adams, “Development and validation of an LC method for the determination of emtricitabine and related compounds in the drug substance,” Journal of Separation Science, vol. 32, no. 11, pp. 1823–1830, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. N. A. Raju and S. Begum, “Simultaneous RP-HPLC method for the estimation of the emtricitabine, tenofovir disoproxil fumarate and efavirenz in tablet dosage forms,” Research Journal of Pharmacy and Technology, vol. 1, no. 4, pp. 522–525, 2008. View at Google Scholar
  26. P. S. Devrukhakar, R. Borkar, N. Shastri, and K. V. Surendranath, “A validated stability-indicating RP-HPLC method for the simultaneous determination of tenofovir, emtricitabine, and a efavirenz and statistical approach to determine the effect of variables,” ISRN Chromatography, vol. 2013, Article ID 878295, 8 pages, 2013. View at Publisher · View at Google Scholar
  27. D. S. Bhavsar, B. N. Patel, and C. N. Patel, “RP-HPLC method for simultaneous estimation of tenofovir disoproxil fumarate, lamivudine, and efavirenz in combined tablet dosage form,” Pharmaceutical Methods, vol. 3, no. 2, pp. 73–78, 2012. View at Publisher · View at Google Scholar
  28. N. A. Gomes, V. V. Vaidya, A. Pudage, S. S. Joshi, and S. A. Parekh, “Liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for simultaneous determination of tenofovir and emtricitabine in human plasma and its application to a bioequivalence study,” Journal of Pharmaceutical and Biomedical Analysis, vol. 48, no. 3, pp. 918–926, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. U. Seshachalam, B. Haribabu, and K. B. Chandrasekhar, “Development and validation of a stability-indicating liquid chromatographic method for determination of emtricitabine and related impurities in drug substance,” Journal of Separation Science, vol. 30, no. 7, pp. 999–1004, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. B. G. Bhavar, S. S. Pekamwar, B. K. Aher, and R. S. Chaudhari, “Development and validation of UV spectrophotometric method for estimation of rilpivirine hydrochloride in bulk and pharmaceutical formulations,” American Journal of PharmTech Research, vol. 3, no. 1, pp. 450–458, 2013. View at Google Scholar
  31. S. Ghosh, S. Bomma, L. V. Prasanna, S. Vidyadhar, D. Banji, and S. Roy, “Method development and validation of rilpivirine in bulk and tablet doses form by RP-HPLC method,” Research Journal of Pharmacy and Technology, vol. 6, no. 3, pp. 240–243, 2013. View at Google Scholar · View at Scopus
  32. T. Sudha and P. Shanmugasundram, “Reverse phase high performance and HPTLC methods for the determination of rilpirivine bulk and in tablet dosage form,” World Journal of Pharmaceutical Research, vol. 1, no. 4, pp. 1183–1196, 2012. View at Google Scholar
  33. ICH Q2(R1) Guideline, Validation of Analytical Procedures: Text and Methodology, ICH, Geneva, Switzerland, 2005.
  34. P. Giriraj and T. Sivakkumar, “Simultaneous estimation of dutasteride and tamsulosin hydrochloride in tablet dosage form by vierordt's method,” Arabian Journal of Chemistry, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. G. H. Jefferey, J. Basset, J. Mendham, and R. C. Denney, Vogels Textbook of Quantitative Chemical Analysis, Longman, London, UK, 5th edition, 1989.
  36. A. H. Beckett and J. B. Stenlake, Practical Pharmaceutical Chemistry, CBS Publishers and Distributors, New Delhi, India, 4th edition, 1997.
  37. R. Sharma and K. Mehta, “Simultaneous spectrophotometric estimation of tenofovir disoproxil fumarate and lamivudine in three component tablet formulation containing efavirenz,” Indian Journal of Pharmaceutical Sciences, vol. 72, no. 4, pp. 527–530, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Khan, R. T. Lohiya, and M. J. Umekar, “Development of UV spectrophotometric method for the simultaneous estimation of meloxicam and paracetamol in tablet by simultaneous equation, absorbance ratio and absorbance correction method,” International Journal of ChemTech Research, vol. 2, no. 3, pp. 1586–1591, 2010. View at Google Scholar · View at Scopus